Skip to main content
SpringerLink
Log in

Pulmonary Hypertension

  • Chapter
  • First Online:
Heart Failure

Part of the book series: Cardiovascular Medicine ((CVM))

  • 2679 Accesses

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH), representing group 4 of the classification of pulmonary hypertension (PH), is defined as a symptomatic PH with a mean pulmonary arterial pressure (PAm) of at least 25 mmHg and normal pulmonary arterial occlusion pressure (PAOP ≤15 mmHg) with pulmonary perfusion defects persisting after a 3 months episode of adequate anticoagulation [5]. Furthermore, there is a mechanical obstructive component, potentially amenable by surgery and a variable degree of secondary vasculopathy [10].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013;99(19):1415–20.

    Article  Google Scholar 

  2. Cannon JE, Su L, Kiely DG, et al. dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom National Cohort. Circulation. 2016;133(18):1761–71.

    Article  Google Scholar 

  3. Daily PO, Dembitsky WP, Iversen S. Technique of pulmonary thromboendarterectomy for chronic pulmonary embolism. J Card Surg. 1989;4(1):10–24.

    Article  CAS  Google Scholar 

  4. Feinstein JA, Goldhaber SZ, Lock JE. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001;103(1):10–3.

    Article  CAS  Google Scholar 

  5. Galié N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–75.

    Article  Google Scholar 

  6. Ghofrani HA, D’Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369(4):319–29.

    Article  CAS  Google Scholar 

  7. Guérin L, Couturaud F, Parent F, et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Haemost. 2014;112(3):598–605.

    Article  Google Scholar 

  8. Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457–62.

    Article  Google Scholar 

  9. Kataoka M, Inami T, Hayashida K, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):756–62.

    Article  Google Scholar 

  10. Keogh AM, Mayer E, Benza RL, et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. 2009;54(1):67–77.

    Article  Google Scholar 

  11. Kim NH, Delcroix M, Jenkins DP, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62(25):D92–9.

    Article  Google Scholar 

  12. Lang IM, Pesavento R, Bonderman D, et al. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41(2):462–8.

    Article  Google Scholar 

  13. Lankeit M, Krieg V, Hobohm L, et al. Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2017;37:250–8. https://doi.org/10.1016/j.healun.2017.06.011.

    Article  Google Scholar 

  14. Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg. 2012;94(1):97–103.

    Article  Google Scholar 

  15. Mayer E. Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2010;19(115):64–7.

    Article  CAS  Google Scholar 

  16. Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141(3):702–10.

    Article  Google Scholar 

  17. Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Minerva Anestesiol. 2012;5(6):748–55.

    Google Scholar 

  18. Ogo T. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Curr Opin Pulm Med. 2015;21:425–31.

    Article  Google Scholar 

  19. Pengo V, Lensing A, Prins M, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. N Engl J Med. 2004;350:2257–64.

    Article  CAS  Google Scholar 

  20. Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124(18):1973–81.

    Article  Google Scholar 

  21. Sato H, Ota H, Sugimura K, et al. Balloon pulmonary angioplasty improves biventricular functions and pulmonary flow in chronic thromboembolic pulmonary hypertension. Circ J. 2016;80(6):1470–7.

    Article  Google Scholar 

  22. Sugimura K, Fukumoto Y, Satoh K, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76(2):485–8.

    Article  Google Scholar 

  23. Taboada D, Pepke-Zaba J, Jenkins DP, et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J. 2014;44:1635–45.

    Article  Google Scholar 

  24. Taniguchi Y, Miyagawa K, Nakayama K, et al. Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. EuroIntervention. 2014;10(4):518–25.

    Article  Google Scholar 

  25. Thistlethwaite PA, Madani M, Jamieson SW. Outcomes of pulmonary endarterectomy surgery. Semin Thorac Cardiovasc Surg. 2006;18(3):257–64.

    Article  Google Scholar 

  26. Voorburg JA, Cats VM, Buis B, Bruschke AV. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest. 1988;94:1249–53.

    Article  CAS  Google Scholar 

  27. Wiedenroth CB, Liebetrau C, Breithecker A, et al. Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2016;35(5):591–6.

    Article  Google Scholar 

  28. Wiedenroth CB, Olsson KM, Guth S, et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease. Pulm Circ. 2018; https://doi.org/10.1177/204589321775312.

  29. Wiedenroth CB, Ghofrani HA, Adameit MSD. Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension. Pulm Circ. 2018; in press.

    Google Scholar 

Download references

Disclosures

CB Wiedenroth has received speaker fees and/or consultant honoraria from Actelion, Bayer AG, BTG, MSD, and Pfizer.

E Mayer has received speaker fees and/or honoraria for consultations from Actelion, Bayer AG, GSK, MSD, and Pfizer.

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany

    Christoph B. Wiedenroth & Eckhard Mayer

Authors
  1. Christoph B. Wiedenroth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eckhard Mayer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph B. Wiedenroth .

Editor information

Editors and Affiliations

  1. Division of Cardiology, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA

    David S. Feldman

  2. Clinic im Park, Cardiovascular Center Zürich, Hirslanden Zurich, Switzerland

    Paul Mohacsi

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wiedenroth, C.B., Mayer, E. (2019). Pulmonary Hypertension. In: Feldman, D., Mohacsi, P. (eds) Heart Failure. Cardiovascular Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-98184-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-98184-0_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-98182-6

  • Online ISBN: 978-3-319-98184-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation